Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases

被引:36
|
作者
Lee, Wang-Soo [1 ]
Ham, Woojin [2 ]
Kim, Jaetaek [2 ]
机构
[1] Chung Ang Univ, Div Cardiol, Dept Internal Med, Coll Med, Seoul 06974, South Korea
[2] Chung Ang Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul 06974, South Korea
来源
LIFE-BASEL | 2021年 / 11卷 / 12期
基金
新加坡国家研究基金会;
关键词
NAD(P)H; quinone oxidoreductase 1; oxidative stress; human diseases; MEMBRANE REDOX SYSTEM; INDUCED DNA-DAMAGE; HIGH-FAT DIET; DT-DIAPHORASE; OXIDATIVE STRESS; NAD(P)H-QUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; BETA-LAPACHONE; PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE;
D O I
10.3390/life11121301
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
NAD(P)H:quinone oxidoreductase (NQO) is an antioxidant flavoprotein that catalyzes the reduction of highly reactive quinone metabolites by employing NAD(P)H as an electron donor. There are two NQO enzymes-NQO1 and NQO2-in mammalian systems. In particular, NQO1 exerts many biological activities, including antioxidant activities, anti-inflammatory effects, and interactions with tumor suppressors. Moreover, several recent studies have revealed the promising roles of NQO1 in protecting against cardiovascular damage and related diseases, such as dyslipidemia, atherosclerosis, insulin resistance, and metabolic syndrome. In this review, we discuss recent developments in the molecular regulation and biochemical properties of NQO1, and describe the potential beneficial roles of NQO1 in diseases associated with oxidative stress.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Molecular characterization of NAD(P)H:quinone oxidoreductase of tobacco leaves
    Sparla, F
    Tedeschi, G
    Pupillo, P
    Trost, P
    PROTOPLASMA, 1998, 205 (1-4) : 52 - 58
  • [32] NAD(P)H:quinone oxidoreductase and susceptibility to acute lung injury
    Reddy, Anita J.
    Marzec, Jacqui
    Gladwell, Wes
    Kleeberger, Steven
    CHEST, 2006, 130 (04) : 86S - 86S
  • [33] NAD(P)H: Quinone oxidoreductase polymorphism and lung cancer in Taiwan
    Lin, PP
    Wang, HJ
    Lee, H
    Lee, HS
    Wang, SL
    Hsueh, YM
    Tsai, KJ
    Chen, CY
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 1999, 58 (04): : 187 - 197
  • [34] Reduction of nitrosoarene by purified NAD(P)H-quinone oxidoreductase
    Kim, K
    Suk, H
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 32 (04): : 321 - 325
  • [35] Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue
    Strassburg, A
    Strassburg, CP
    Manns, MP
    Tukey, RH
    MOLECULAR PHARMACOLOGY, 2002, 61 (02) : 320 - 325
  • [36] Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1
    Siegel, D
    McGuinness, SM
    Winski, SL
    Ross, D
    PHARMACOGENETICS, 1999, 9 (01): : 113 - 121
  • [37] NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
    Zhang, Kuojun
    Chen, Dong
    Ma, Kun
    Wu, Xiaoxing
    Hao, Haiping
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 6983 - 7003
  • [38] Association of NAD(P)H:Quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese
    Bian, Jian-Tao
    Zhao, Hua-Lu
    Zhang, Zhen-Xin
    Bi, Xiu-Hua
    Zhang, Jun-Wu
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 34 (03) : 235 - 240
  • [39] Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:Quinone oxidoreductase 1
    Siegel, D
    Anwar, A
    Winski, SL
    Kepa, JK
    Zolman, KL
    Ross, D
    MOLECULAR PHARMACOLOGY, 2001, 59 (02) : 263 - 268
  • [40] NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase) in bioactivation
    Ross, D
    Siegel, D
    Dehn, DL
    Winski, SL
    DRUG METABOLISM REVIEWS, 2002, 34 : 20 - 20